Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04432857
Title AN0025 and Pembrolizumab Combination in Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Adlai Nortye Biopharma Co., Ltd.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | FRA


No variant requirements are available.